866-997-4948(US-Canada Toll Free)

Global Monoclonal antibodies (mAbs) Biosimilars Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 90 Pages

This report studies the global market size of Monoclonal antibodies (mAbs) Biosimilars in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Monoclonal antibodies (mAbs) Biosimilars in these regions.
This research report categorizes the global Monoclonal antibodies (mAbs) Biosimilars market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

A biosimilar medicine is a medicinal product of biological origin that is produced in a living organism following a procedure equivalent to a biological drug and adhering to the same quality criteria, hence the name biosimilars. In short, they are biological drugs that are equivalent in terms of quality, efficacy and safety to an innovative reference medicinal product.
According to the report, one driver that will lead to the growth of this market is the rise in number of patent expiries.
In 2017, the global Monoclonal antibodies (mAbs) Biosimilars market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Monoclonal antibodies (mAbs) Biosimilars market based on company, product type, application and key regions.

The various contributors involved in the value chain of Monoclonal antibodies (mAbs) Biosimilars include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Monoclonal antibodies (mAbs) Biosimilars include
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Amega Biotech
Others

Market Size Split by Type
Erythropoietin (EPO)
Human Growth Hormone (HGH)
Granulocyte- Colony Stimulating Factor (G-CSF)
Monoclonal Antibody (mAb)
Insulin
Interferon (IFN)
Others
Market Size Split by Application
Anti-Cancer
Anti-Inflammatory/Autoimmune

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Monoclonal antibodies (mAbs) Biosimilars market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Monoclonal antibodies (mAbs) Biosimilars market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Monoclonal antibodies (mAbs) Biosimilars manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Monoclonal antibodies (mAbs) Biosimilars with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Monoclonal antibodies (mAbs) Biosimilars submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Monoclonal antibodies (mAbs) Biosimilars are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Monoclonal antibodies (mAbs) Biosimilars market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Monoclonal antibodies (mAbs) Biosimilars Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Type
1.4.2 Erythropoietin (EPO)
1.4.3 Human Growth Hormone (HGH)
1.4.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.4.5 Monoclonal Antibody (mAb)
1.4.6 Insulin
1.4.7 Interferon (IFN)
1.4.8 Others
1.5 Market by Application
1.5.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Application
1.5.2 Anti-Cancer
1.5.3 Anti-Inflammatory/Autoimmune
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size
2.1.1 Global Monoclonal antibodies (mAbs) Biosimilars Revenue 2016-2025
2.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Sales 2016-2025
2.2 Monoclonal antibodies (mAbs) Biosimilars Growth Rate by Regions
2.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales by Regions
2.2.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Monoclonal antibodies (mAbs) Biosimilars Sales by Manufacturers
3.1.1 Monoclonal antibodies (mAbs) Biosimilars Sales by Manufacturers
3.1.2 Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Manufacturers
3.1.3 Global Monoclonal antibodies (mAbs) Biosimilars Market Concentration Ratio (CR5 and HHI)
3.2 Monoclonal antibodies (mAbs) Biosimilars Revenue by Manufacturers
3.2.1 Monoclonal antibodies (mAbs) Biosimilars Revenue by Manufacturers (2016-2018)
3.2.2 Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Manufacturers (2016-2018)
3.3 Monoclonal antibodies (mAbs) Biosimilars Price by Manufacturers
3.4 Monoclonal antibodies (mAbs) Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 Monoclonal antibodies (mAbs) Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Monoclonal antibodies (mAbs) Biosimilars Product Category
3.4.3 Date of International Manufacturers Enter into Monoclonal antibodies (mAbs) Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales by Type
4.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Type
4.3 Monoclonal antibodies (mAbs) Biosimilars Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Monoclonal antibodies (mAbs) Biosimilars Breakdown Data by Application

6 North America
6.1 North America Monoclonal antibodies (mAbs) Biosimilars by Countries
6.1.1 North America Monoclonal antibodies (mAbs) Biosimilars Sales by Countries
6.1.2 North America Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Monoclonal antibodies (mAbs) Biosimilars by Type
6.3 North America Monoclonal antibodies (mAbs) Biosimilars by Application
6.4 North America Monoclonal antibodies (mAbs) Biosimilars by Company

7 Europe
7.1 Europe Monoclonal antibodies (mAbs) Biosimilars by Countries
7.1.1 Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Countries
7.1.2 Europe Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Monoclonal antibodies (mAbs) Biosimilars by Type
7.3 Europe Monoclonal antibodies (mAbs) Biosimilars by Application
7.4 Europe Monoclonal antibodies (mAbs) Biosimilars by Company

8 Asia Pacific
8.1 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars by Countries
8.1.1 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Countries
8.1.2 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars by Type
8.3 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars by Application
8.4 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars by Company

9 Central & South America
9.1 Central & South America Monoclonal antibodies (mAbs) Biosimilars by Countries
9.1.1 Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales by Countries
9.1.2 Central & South America Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Monoclonal antibodies (mAbs) Biosimilars by Type
9.3 Central & South America Monoclonal antibodies (mAbs) Biosimilars by Application
9.4 Central & South America Monoclonal antibodies (mAbs) Biosimilars by Company

10 Middle East and Africa
10.1 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars by Countries
10.1.1 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Countries
10.1.2 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars by Type
10.3 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars by Application
10.4 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars by Company

11 Company Profiles
11.1 Biocon
11.1.1 Biocon Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
11.1.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
11.1.5 Recent Development
11.2 Celltrion
11.2.1 Celltrion Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
11.2.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
11.2.5 Recent Development
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
11.3.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
11.3.5 Recent Development
11.4 Hospira
11.4.1 Hospira Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
11.4.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
11.4.5 Recent Development
11.5 3SBio
11.5.1 3SBio Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
11.5.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
11.5.5 Recent Development
11.6 Accord Healthcare
11.6.1 Accord Healthcare Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
11.6.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
11.6.5 Recent Development
11.7 AET Biotech
11.7.1 AET Biotech Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
11.7.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
11.7.5 Recent Development
11.8 Allergan
11.8.1 Allergan Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
11.8.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
11.8.5 Recent Development
11.9 Amega Biotech
11.9.1 Amega Biotech Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
11.9.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
11.9.5 Recent Development
11.10 Others
11.10.1 Others Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Monoclonal antibodies (mAbs) Biosimilars
11.10.4 Monoclonal antibodies (mAbs) Biosimilars Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Monoclonal antibodies (mAbs) Biosimilars Raw Material
13.1.2 Monoclonal antibodies (mAbs) Biosimilars Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Monoclonal antibodies (mAbs) Biosimilars
Figure Global Monoclonal antibodies (mAbs) Biosimilars Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Production Market Share by Types (Product Category) in 2017
Figure Erythropoietin (EPO) Product Picture
Table Major Manufacturers of Erythropoietin (EPO)
Figure Human Growth Hormone (HGH) Product Picture
Table Major Manufacturers of Human Growth Hormone (HGH)
Figure Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture
Table Major Manufacturers of Granulocyte- Colony Stimulating Factor (G-CSF)
Figure Monoclonal Antibody (mAb) Product Picture
Table Major Manufacturers of Monoclonal Antibody (mAb)
Figure Insulin Product Picture
Table Major Manufacturers of Insulin
Figure Interferon (IFN) Product Picture
Table Major Manufacturers of Interferon (IFN)
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Monoclonal antibodies (mAbs) Biosimilars Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Anti-Cancer
Figure Anti-Inflammatory/Autoimmune
Figure Monoclonal antibodies (mAbs) Biosimilars Report Years Considered
Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size 2016-2025 (Million US$)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales 2016-2025 (K Units)
Table Global Monoclonal antibodies (mAbs) Biosimilars Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Regions 2016-2025 (K Units)
Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Regions 2016-2025
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Regions 2016-2025
Figure 2017 Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Regions
Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Regions 2016-2025 (Million US$)
Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Regions 2016-2025
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Regions 2016-2025
Figure 2017 Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Regions
Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Manufacturers (2016-2018) (K Units)
Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Share by Manufacturers (2016-2018)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Share by Manufacturers in 2017
Table Monoclonal antibodies (mAbs) Biosimilars Revenue by Manufacturers (2016-2018) (Million US$)
Table Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Manufacturers (2016-2018)
Figure Monoclonal antibodies (mAbs) Biosimilars Value Share by Manufacturers in 2017
Table Global Monoclonal antibodies (mAbs) Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Monoclonal antibodies (mAbs) Biosimilars Price (2016-2018) (USD/Unit)
Table Monoclonal antibodies (mAbs) Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Monoclonal antibodies (mAbs) Biosimilars Product Category
Table Date of International Manufacturers Enter into Monoclonal antibodies (mAbs) Biosimilars Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Share by Type (2016-2025)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type in 2017
Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue by Type (2016-2025) (Million US$)
Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue Share by Type (2016-2025)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2016-2025)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type in 2017
Table Monoclonal antibodies (mAbs) Biosimilars Price by Type 2013-2018 (USD/Unit)
Table Global Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Share by Application (2016-2025)
Figure Global Sales Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2025)
Figure Global Sales Monoclonal antibodies (mAbs) Biosimilars Market Share by Application (2016-2025)
Figure North America Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate 2016-2025 (K Units)
Figure North America Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table North America Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2016-2025) (K Units)
Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries
Table North America Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table North America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries
Figure United States Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure United States Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Canada Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table North America Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type
Table North America Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 North America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application
Table North America Monoclonal antibodies (mAbs) Biosimilars Sales by Company (2016-2018) (K Units)
Table North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company (2016-2018)
Figure North America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company in 2017
Figure Europe Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate 2016-2025 (K Units)
Figure Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2016-2025) (K Units)
Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries
Table Europe Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries
Figure Germany Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Germany Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (K Units)
Figure France Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure France Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (K Units)
Figure UK Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure UK Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Italy Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Russia Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Type
Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Europe Monoclonal antibodies (mAbs) Biosimilars Market Share by Application
Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales by Company (2016-2018) (K Units)
Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company (2016-2018)
Figure Europe Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company in 2017
Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries
Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries
Figure China Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure China Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Japan Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Korea Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure India Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure India Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Australia Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Type
Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Market Share by Application
Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales by Company (2016-2018) (K Units)
Table Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company (2016-2018)
Figure Asia Pacific Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company in 2017
Figure Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2016-2025) (K Units)
Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries
Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries
Figure Brazil Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Share by Type
Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Monoclonal antibodies (mAbs) Biosimilars Market Share by Application
Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales by Company (2016-2018) (K Units)
Table Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company (2016-2018)
Figure Central & South America Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company in 2017
Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Countries
Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Countries
Figure GCC Countries Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Monoclonal antibodies (mAbs) Biosimilars Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Monoclonal antibodies (mAbs) Biosimilars Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Type
Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Share by Application
Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Market Share by Company in 2017
Table Biocon Company Details
Table Biocon Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Biocon Recent Development
Table Celltrion Company Details
Table Celltrion Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Celltrion Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Dr. Reddy's Laboratories Recent Development
Table Hospira Company Details
Table Hospira Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Hospira Recent Development
Table 3SBio Company Details
Table 3SBio Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table 3SBio Recent Development
Table Accord Healthcare Company Details
Table Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Accord Healthcare Recent Development
Table AET Biotech Company Details
Table AET Biotech Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AET Biotech Recent Development
Table Allergan Company Details
Table Allergan Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Allergan Recent Development
Table Amega Biotech Company Details
Table Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Amega Biotech Recent Development
Table Others Company Details
Table Others Monoclonal antibodies (mAbs) Biosimilars Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Others Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Monoclonal antibodies (mAbs) Biosimilars Value Chain
Table Typical Suppliers of Key Monoclonal antibodies (mAbs) Biosimilars Raw Material
Table Monoclonal antibodies (mAbs) Biosimilars Customers List
Table Monoclonal antibodies (mAbs) Biosimilars Sales Channels
Table Monoclonal antibodies (mAbs) Biosimilars Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *